Published in Cancer Weekly, May 10th, 2005
Capridine-Beta is a novel nitroacridine derivative, which has shown specific activity against prostate cancer. It works by stimulating expression of p16, the tumor-suppressor gene and inhibits cyclic dependent kinases CDK-2, CDK-4 and CDK-6. Capridine-Beta also renders aggressive hormone-independent prostate cells hormone-sensitive.
Therefore, Capridine-Beta may be effective in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.